Ładuje się......
Examining HSD3B1 as a possible biomarker to detect prostate cancer patients who are likely to progress on ADT
The Chemohormonal Therapy vs Androgen Ablation Randomized Trial for Extensive Disease in Prostate Cancer (CHAARTED) was a randomized phase III trial that evaluated the outcomes of men with metastatic prostate cancer who received castration with or without docetaxel. Patients from this trial were gen...
Zapisane w:
| Wydane w: | Cancer Biol Ther |
|---|---|
| Główni autorzy: | , , , |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
Taylor & Francis
2020
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7515525/ https://ncbi.nlm.nih.gov/pubmed/32791030 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15384047.2020.1796195 |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|